Physician profile
Travis Gilbert
NPI 1770093619
$2,263.73
in general payments reported to CMS, 2019-2025
18 companies · $720 in 2025
The $720 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $266 · 2022: $217 · 2023: $276 · 2024: $785 · 2025: $720.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,606 · Education: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,605.84 |
| Education | $174.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,019.50 | 2021-2025 | |
| Janssen Biotech, INC. | $423.40 | 2021-2025 | Tremfya, Simponi Aria, Stelara |
| E.R. Squibb & Sons, L.L.C. | $173.65 | 2022-2025 | Sotyktu |
| Lilly USA, LLC | $135.16 | 2024-2025 | Taltz, Olumiant, Ebglyss |
| Novartis Pharmaceuticals Corporation | $103.84 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $77.55 | 2022-2024 | Dupixent |
| Ucb, INC. | $71.82 | 2024-2025 | Bimzelx |
| Sun Pharmaceutical Industries INC. | $64.95 | 2021-2024 | |
| Pfizer INC. | $36.86 | 2021-2022 | |
| Genzyme Corporation | $33.57 | 2021 | |
| Organogenesis INC. | $23.09 | 2024 | Puraply Am |
| Incyte Corporation | $18.92 | 2024 | Opzelura |
| Arcutis Biotherapeutics, INC. | $14.77 | 2023 | |
| Mayne Pharma Commercial LLC | $14.23 | 2021 | |
| Dermavant Sciences, INC. | $14.00 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $13.12 | 2025 | Vtama |
| Leo Pharma INC. | $12.65 | 2021 | |
| Biofrontera INC. | $12.65 | 2023 | Xepi, Bf-Rhodoled, Ameluz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Gilbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.